非共面VMAT用于肺部SABR以降低心脏剂量:一项计划研究
回顾性选取20例肿瘤靠近心脏的肺癌SABR患者,比较非共面部分弧(NPA)与共面部分弧(CPA)VMAT计划。NPA组心脏D0.1cc为21.71±9.20 Gy,低于CPA组的29.42±13.37 Gy(p<0.001);全身平均剂量和梯度指数也优于CPA组(均p<0.001)。NPA VMAT计划质量更优。
要点
- 对于肿瘤靠近心脏的肺癌SABR,NPA VMAT较CPA VMAT可降低心脏D0.1cc。
- NPA VMAT的全身平均剂量和梯度指数均低于CPA VMAT(均p<0.001)。
- PTV和双肺剂量学参数在两种计划间总体无统计学显著差异。
核心结论
- NPA VMAT用于肿瘤靠近心脏的肺癌SABR时,计划质量优于CPA VMAT,可降低心脏剂量及全身照射。
研究设计与样本
- 回顾性计划研究,纳入20例接受SABR VMAT技术治疗且肺部肿瘤靠近心脏的肺癌患者;CPA VMAT使用三个共面半弧,NPA VMAT使用两个共面半弧和一个旋转315°-45°的非共面弧(床旋转315°±5°);每位患者两种计划使用相同CT图像集和相同结构;分析剂量体积参数。
诊断标准与关键数值
- 心脏D0.1cc:CPA VMAT组29.42±13.37 Gy vs NPA VMAT组21.71±9.20 Gy,NPA组降低(p<0.001)。
- 全身平均剂量:CPA VMAT组1.2±0.5 Gy vs NPA VMAT组1.1±0.5 Gy,NPA组降低(p<0.001)。
- 梯度指数:CPA VMAT组4.356±0.608 vs NPA VMAT组4.111±0.480,NPA组降低(p<0.001)。
- PTV和双肺的剂量体积参数在CPA与NPA VMAT计划间总体无统计学显著差异。
临床应用与阅片要点
- 对于肿瘤靠近心脏的肺癌SABR,可参考NPA VMAT计划以降低心脏D0.1cc。
- NPA VMAT可能降低全身平均剂量和梯度指数,但PTV和双肺剂量参数与CPA VMAT总体无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to compare the plan quality of non-coplanar partial arc (NPA) volumetric modulated arc therapy (VMAT) to that of coplanar partial arc (CPA) VMAT for stereotactic ablative radiotherapy (SABR) for lung cancer.
METHODS: A total of 20 patients treated for lung cancer with the SABR VMAT technique and whose lung tumors were close to the heart were retrospectively selected for this study. For the CPA VMAT, three coplanar half arcs were used while two coplanar half arcs and one noncoplanar arc rotating 315°-45° with couch rotations of 315° ± 5° were used for the NPA VMAT. For each patient, identical CT image sets and identical structures were used for both the CPA and NPA VMAT plans. Dose-volumetric parameters of each plan were analyzed.
RESULTS: For the planning target volume and both lungs, no statistically significant differences between the CPA and NPA VMAT plans were observed in general. For the heart, average values of D0.1cc of the CPA and NPA VMAT plans were 29.42 ± 13.37 and 21.71 ± 9.20 Gy, respectively (p < 0.001). For whole body, the mean dose and the gradient index of the CPA VMAT plans were 1.2 ± 0.5 Gy and 4.356 ± 0.608 while those of the NPA VMAT plans were 1.1 ± 0.5 Gy and 4.111 ± 0.480, respectively (both with p < 0.001).
CONCLUSION: The NPA VMAT proposed in this study showed more favorable plan quality than the CPA VMAT plans for lung SABR with tumors located close to the heart.
ADVANCES IN KNOWLEDGE: For lung SABR, NPA VMAT can reduce doses to the heart as well as whole-body irradiation.
引用
- Kim ST, An HJ, Kim JI, et al. Non-coplanar VMAT plans for lung SABR to reduce dose to the heart: a planning study. Br J Radiol. 2019. PMID: 31625759. doi:10.1259/bjr.20190596
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。